Anti-KAP1/TIF1β Antibody (4E1-D12-F8)

Anti-KAP1/TIF1β Antibody (4E1-D12-F8)is available at Gentaur for Next week Delivery.

Description: Transcription intermediary factor 1-beta mediates transcriptional control by interaction with the Kruppel-associated box repression domain found in many transcription factors. The protein localizes to the nucleus and is thought to associate with specific chromatin regions. The protein is a member of the tripartite motif family. This tripartite motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region.

Immunogen Sequence:Recombinant human KAP1/TIF1 beta protein fragments expressed in E.coli

Target Alternative Name:E3 SUMO protein ligase TRIM28; E3 SUMO-protein ligase TRIM28; FLJ29029;KAP 1; KAP-1; KRAB associated protein 1; KRAB interacting protein 1; KRAB-ass ociated protein 1; KRAB-interacting protein 1; KRIP 1; KRIP-1; KRIP1; Nuclear corepressor KAP 1; Nuclear corepressor KAP-1; RING finger protein 96; RNF96; TF1B; TIF1 beta; TIF1-beta; TIF1B; TIF1B_HUMAN; Transcription intermediary factor 1 beta; Transcription intermediary factor 1-beta; TRIM28; Tripartite motif containing 28; tripartite motif containing protein 28; Tripartite motif-containing protein 28.

Species Reactivities:Human

Tag Line:Monoclonal antibody to detect KAP1/TIF1β

Formulation:In buffer containing 0.1M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.2% sodium azide, 50%,glycerol

Purification: Affinity purified

Application:WB, IF, IHC, IP

Positive Control:WB: 293T, Hepg2 cells; IP: HeLa cells; IF: HeLa cells; IHC: human spleen tissue

Application And Usages:WB; 1:1000; IF; 1:100; IHC; IP

Handling:The antibody solution should be gently mixed before use